Please use this identifier to cite or link to this item:
Title: Whole-genome array-CGH screening in undiagnosed syndromic patients: old syndromes revisited and new alterations
Authors: Krepischi-Santos, A. C. V.
Vianna-Morgante, A. M.
Jehee, F. S.
Passos-Bueno, M. R.
Knijnenburg, J.
Szuhai, K.
Sloos, W.
Mazzeu, J. F.
Kok, F.
Cheroki, C.
Otto, P. A.
Mingroni-Netto, R. C.
Varela, M.
Koiffmann, C.
Kim, C. A.
Bertola, D. R.
Pearson, P. L.
Rosenberg, C.
Universidade de São Paulo (USP)
Leiden Univ
Universidade Federal de São Paulo (UNIFESP)
Robinow Syndrome Fdn
Issue Date: 1-Jan-2006
Publisher: Karger
Citation: Cytogenetic and Genome Research. Basel: Karger, v. 115, n. 3-4, p. 254-261, 2006.
Abstract: We report array-CGH screening of 95 syndromic patients with normal G-banded karyotypes and at least one of the following features: mental retardation, heart defects, deafness, obesity, craniofacial dysmorphisms or urogenital tract malformations. Chromosome imbalances not previously detected in normal controls were found in 30 patients (31%) and at least 16 of them (17%) seem to be causally related to the abnormal phenotypes. Eight of the causative imbalances had not been described previously and pointed to new chromosome regions and candidate genes for specific phenotypes, including a connective tissue disease locus on 2p16.3, another for obesity on 7q22.1 -> q22.3, and a candidate gene for the 3q29 deletion syndrome manifestations. the other causative alterations had already been associated with well-defined phenotypes including Sotos syndrome, and the 1p36 and 22q11.21 microdeletion syndromes. However, the clinical features of these latter patients were either not typical or specific enough to allow diagnosis before detection of chromosome imbalances. for instance, three patients with overlapping deletions in 22q11.21 were ascertained through entirely different clinical features, i.e., heart defect, utero-vaginal aplasia, and mental retardation associated with psychotic disease. Our results demonstrate that ascertainment through whole-genome screening of syndromic patients by array-CGH leads not only to the description of new syndromes, but also to the recognition of a broader spectrum of features for already described syndromes. Furthermore, on the technical side, we have significantly reduced the amount of reagents used and costs involved in the array-CGH protocol, without evident reduction in efficiency, bringing the method more within reach of centers with limited budgets. Copyright (c) 2006 S. Karger AG, Basel.
ISSN: 1424-8581
Other Identifiers:
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.